Abstract:Abstract Background Sepsis is a life-threatening condition accompanied by organ dysfunction subsequent to a dysregulated host response to infection. Up to 60% of patients with sepsis develop acute kidney injury (AKI), which is associated with a poor clinical outcome. The pathophysiology of sepsis-associated AKI (sepsis-AKI) remains incompletely understood, but mitochondria have emerged as key players in the pathogenesis. Therefore, our aim was to identify mitochondrial damage in patients with sepsis-AKI. Methods We conducted a clinical laboratory study using “warm” postmortem biopsies from sepsis-associated AKI patients from a university teaching hospital. Biopsies were taken from adult patients ( n = 14) who died of sepsis with AKI at the intensive care unit (ICU) and control patients ( n = 12) undergoing tumor nephrectomy. To define the mechanisms of the mitochondrial contribution to the pathogenesis of sepsis-AKI, we explored mRNA and DNA expression of mitochondrial quality mechanism pathways, DNA oxidation and mitochondrial DNA (mtDNA) integrity in renal biopsies from sepsis-AKI patients and control subjects. Next, we induced human umbilical vein endothelial cells (HUVECs) with lipopolysaccharide (LPS) for 48 h to mimic sepsis and validate our results in vitro. Results Compared to control subjects, sepsis-AKI patients had upregulated mRNA expression of oxidative damage markers, excess mitochondrial DNA damage and lower mitochondrial mass. Sepsis-AKI patients had lower mRNA expression of mitochondrial quality markers TFAM , PINK1 and PARKIN , but not of MFN2 and DRP1 . Oxidative DNA damage was present in the cytosol of tubular epithelial cells in the kidney of sepsis-AKI patients, whereas it was almost absent in biopsies from control subjects. Oxidative DNA damage co-localized with both the nuclei and mitochondria. Accordingly, HUVECs induced with LPS for 48 h showed an increased mnSOD expression, a decreased TFAM expression and higher mtDNA damage levels. Conclusion Sepsis-AKI induces mitochondrial DNA damage in the human kidney, without upregulation of mitochondrial quality control mechanisms, which likely resulted in a reduction in mitochondrial mass.

Mitochondrial dysfunction and acute renal injury in sepsis

Mitochondria in Sepsis-Induced AKI.

Changes in mitochondrial metabolism and morphology contribute to sepsis‐associated acute kidney injury (1134.10)

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Lactate‐mitochondrial crosstalk: A new direction in the treatment of sepsis‐induced acute kidney injury

Disturbance of mitochondrial dynamics and mitophagy in sepsis-induced acute kidney injury

Mitochondrial dysfunction in acute kidney injury

Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications

Sepsis-induced AKI: From pathogenesis to therapeutic approaches

Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

Advances in metabolic reprogramming of renal tubular epithelial cells in sepsis-associated acute kidney injury

Mesenchymal Stem Cell Therapy Targeting Mitochondrial Dysfunction in Acute Kidney Injury

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

Recent advances in the pharmacological management of sepsis-associated acute kidney injury

Mitochondrial dysfunction and resuscitation in sepsis

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications

The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

Sepsis is associated with mitochondrial DNA damage and a reduced mitochondrial mass in the kidney of patients with sepsis-AKI

Urinary Mitochondrial DNA Identifies Renal Dysfunction and Mitochondrial Damage in Sepsis-Induced Acute Kidney Injury